JVM's flagship product "New Slide Premier (NSP)" has successfully settled in a pharmaceutical factory-type pharmacy in Europe./ Courtesy of JVM
JVM's flagship product "New Slide Premier (NSP)" has successfully settled in a pharmaceutical factory-type pharmacy in Europe./ Courtesy of JVM

 

JVM's flagship product "New Slide Premier (NSP)," which combines drug classification, packaging and inspection functions, has successfully settled in a pharmaceutical factory-type pharmacy in Europe and Norway, the company said on Oct. 7.

JVM, a subsidiary of Hanmi Science, is an innovative company that has secured 70% of shares in overseas markets for automated pouch-type medicine preparation.

The company said it has confirmed various advantages, including additional manpower savings, as a result of the introduction and operation of NSP by the N medicine preparing factory pharmacy, a subsidiary of Europe and Norway, which was recently established by the U.S. largest Drug Wholesaler.

JVM explained that most overseas factory-type pharmacies are mass dispensing and shipping the received prescription drugs to various parts of the country, which is expected to introduce additional NSP that can greatly increase work efficiency.

NSP is equipped with the latest technology (ARDTM, Automatic Re-dispensing) that automatically re-dispense drugs as soon as they are detected.
Kim Sun-kyung, vice president of JVM, said, "The NSP, which has fully implemented the latest automatic re-dispensing technology, can greatly reduce the work of pharmacists who have to redo the wrong preparation, and greatly increase efficiency."

 

 

저작권자 © The Korea Post 무단전재 및 재배포 금지